- 更多网络例句与抗血小板的相关的网络例句 [注：此内容来源于网络，仅供参考]
-
Fluorescein isothiocyanate labeled polyclonal goat antihuman immunoglobulin antibody was added, and flow cytometer was used to detect bead-platelet-associated autoantibodies-antihuman immunoglobulin antibody complex. Results The fluorescene ratio of four monoclonal antibodies was significantly different (P.01) between the idiopathic thrombocytopenic purpura patients and either the non-ITP patients or the normal controls. If the upper limit of normal control was set as cutoff value, ratios of greater than 1.37, 1.24, 1.48 and 1.19 were considered positive for the four monoclonal antibodies respectively. The flow cytometric bead assay had an overall sensitivity of 73.17% and a specificity of 94.29%. The overall sensitivity was significantly higher (P.05) than that of modified indirect MAIPA and that of using single antibody.
结果 特发性血小板减少性紫痕组4种羊抗荧光强度比值与非ITP血小板减少组和正常对照组有显著性差异(P.01)；若将ITP组患者4种羊抗荧光强度比值分别大于正常对照组上限1.37、1.24、1.48和1.19判断为阳性，则流式微球技术检测血小板特异性自身抗体的敏感性为73.2%，特异性为94.3%；4种羊抗联合检测总体敏感性明显高于改良间接单抗特异的血小板抗原固定试验(P.05)，且大于各单个抗体检测敏感性。
-
Fluorescein isothiocyanate labeled polyclonal goat antihuman immunoglobulin antibody was added, and flow cytometer was used to detect bead-platelet-associated autoantibodies-antihuman immunoglobulin antibody complex. Results The fluorescene ratio of four monoclonal antibodies was significantly different (P .01) between the idiopathic thrombocytopenic purpura patients and either the non-ITP patients or the normal controls. If the upper limit of normal control was set as cutoff value, ratios of greater than 1.37, 1.24, 1.48, and 1.19 were considered positive for the four monoclonal antibodies respectively. The flow cytometric bead assay had an overall sensitivity of 73.17% and a specificity of 94.29%.
结果 特发性血小板减少性紫癜组4种单抗荧光强度比值与非ITP血小板减少组和正常对照组有显著性差异（P＜0.01）；若将ITP组患者4种单抗荧光强度比值分别大于正常对照组上限1.37、1.24、1.48和1.19判断为阳性，则流式微球技术检测血小板特异性自身抗体的敏感性为73.17%，特异性为94.3%；4种单抗联合检测总体敏感性明显高于改良间接单抗特异的血小板抗原固定试验（P＜0.05，且大于各单个抗体检测敏感性。
-
The treatment aimed at the blood platelet may slow down the development of DN.
因此，抗血小板的治疗可能减缓DN的进展。
-
The Pathological changes of immune vasculitis were analyzed by hematoxylin and eosin staining, elastic fibers staining and electron microscopy.
目的 分析丹参酮ⅡA对免疫性血管炎、血小板及凝血活性的影响，探讨其抗血小板、抗凝及降低免疫性血管炎炎症反应的机理。
-
Objective To explore the effect of-epigallocatechin gallate, main component of green tea, on platelet aggregation and activation, to establish the foundation of development of new anti-platelet drug.
目的 对绿茶的主要成分表没食子儿茶素没食子酸酯对血小板聚集、人富含血小板血浆产生TXB2、P-selectin以及血小板膜糖蛋白P-selectin表达水平的影响进行研究，探讨EGCG对血小板聚集、活化的影响，为进一步开发抗血小板药物提供依据。
-
However, studies of the use of antiplatelet agents within 48 hours of the ictus have examined only aspirin.
抗血小板治疗在急性脑梗死治疗中占有重要地位，传统抗血小板治疗主要为口服阿司匹林，但其由于存在给药途径单一、阿司匹林抵抗等问题，使其在急性脑梗死中的应用受到了一定限制。
-
Antiplatelet therapy was given to all patients, immediately after IAT or 24 hours after IVT, irrespective whether their ictus happened while on antiplatelet agents or not.
所有患者无论其病前是否接受了抗血小板治疗：接受动脉溶栓治疗的患者于治疗后，立即予抗血小板治疗；接受静脉溶栓治疗的患者于治疗结束24小时后，予抗血小板治疗。
-
And have improvement microcirculation , resist blood platelet aggregation and thrombopoiesis, can make blood viscosity come down , improve blood circulation.
还具有改善微循环、抗血小板的聚集和血栓形成，并能使血液粘度下降，改善血液循环。
-
The comparison between aspirin and clopidogrel: The incremental cost-effectiveness ratio between aspirin and clopidogrel is NTD 9,699,399 per QALY. In sensitivity analyses, the efficacy and drug prices of antiplatelet agents are key factors to determine the ICER compared with aspirin.
进行单维敏感性分析时发现，变项为「抗血小板药物对於预防中风复发的效果」以及「抗血小板药物药价」，此两项变项的改变会造成边际效益比值变化甚大，进而可能影响研究结论之改变。
-
"Overall, the data are the data: they're probably right," Dr Ron Waksman commented, noting that a recent paper from his group showed similar findings. The problem is that most people will generalize from these conclusions after publication, and there is three-vessel disease and there is three-vessel disease. Not all three-vessel disease is the same.
也有人指出CABG和支架组是否完全再血管化还缺乏资料，也没有二联抗血小板治疗的资料，Joseph P Carrozza (Harvard Medical School， Boston， MA)在述评中指出Hannan等的研究要注意延长二联抗血小板治疗的问题，DES治疗的患者较短期的二联抗血小板治疗可能会导致更多的死亡。
- 更多网络解释与抗血小板的相关的网络解释 [注：此内容来源于网络，仅供参考]
-
aspirin：阿斯匹灵
临床上,有位外国医师(Fontaine)依症状严重度分为四期:(一) 阿斯匹灵(Aspirin)、保栓通膜衣锭(plavix)及其他抗血小板药物周边血管阻塞疾病的治疗有许多方式,但绝大部分无法改变血管已经病变的事实,所以这类疾病再预防其发生的重要性是不言而谕的,
-
iron dextran：右旋糖酐铁
从而抑制血小板与纤维蛋白原的结合而产生抗血小板聚集作用.主要用于防治动脉血栓栓塞性疾病,如脑血栓,缺血性心脏病,血管闭塞性脉管炎等.制剂:硫酸亚铁(Ferrous sulfate)枸橼酸铁铵(Ferric ammonium citrate)右旋糖酐铁(Iron dextran),富马酸亚铁(ferrous fumarate),
-
JAMA：美国医学会会刊
2008-2009年,ACCF/ACG/AHA专家共识和>(JAMA)回顾性分析的发表,引发了学术界对存在胃肠道出血高危因素的ACS患者进行双联抗血小板治疗决策的质疑.
-
prostaglandin：前列腺素
88%前列腺素(Prostaglandin)产生,故非类固醇抗发炎止痛剂(NSAIDs)的使用会减少甘菊的作用. 甘菊同时也有抑制血小板的作用,对于正在使用Warfarin及其他抗凝血剂的患者应避免使用. 孕妇不可使用甘菊,因它会有催经的效果.
-
antiplatelet：抗血小板
2.1 抗血小板(Antiplatelet)治疗抗血小板药是在缺血性卒中预防和治疗的众多药物中研究最充分、证据最多的一类药物. 抗血小板药主要包括血栓素A2抑制剂(阿司匹林)、腺苷二磷酸(ADP)受体拮抗剂(氯吡格雷和噻氯匹定)、磷酸二酯酶抑制剂(双嘧达莫)、糖蛋白(GP)IIb/IIIa受体阻滞剂(阿昔单抗)等.
-
antiplatelet：抗血小板的
抗血纤维蛋白溶素antiplasmin | 抗血小板的antiplatelet | 抗血友病药antihemophilic
-
antipleion：负偏差中心/歉准区
antiplatelet /抗血小板的/ | antipleion /负偏差中心/歉准区/ | antipodal /对跖地的/对跖的/正相反的/
-
antitrypsin：抗胰蛋白酶
Hirsh等指出,血细胞和血浆蛋白质的改变,有助于脉血栓的形成,如血小板黏附性增强、血小板计数增加、血浆纤维蛋白原增高、凝血因子增多和抗纤维蛋白溶解酶,尤其是a2-球蛋白和a1-抗胰蛋白酶 (antitrypSin)的含量升高等.
-
Gingerol：姜辣素
注:姜 辣素(gingerol)能抑制肠内的异常发酵和促积气排出. 具有健胃抗胃溃疡、利胆、保肝、强心、抑制血小板聚集、防晕、抗肿瘤、中枢抑制、增强免疫力、抗菌、杀虫、消炎之作用,还具有很强 的抗氧化能 力.
-
Vanillic acid：香草酸
苑艳光在刺五加茎中具抗血小板凝集作用的活性成分研究中发现下列成分:香草酸(Vanillic acid)、丁香酸(Syrinigic acid)、酪醇、异香草醛(Isovanillin)、异秦皮啶、丁香苷、阿魏酸葡萄糖苷(Feruloyl sucrose)等.